Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology
Clinical trial NCT01626547 · COMPLETED
Trial details
- NCT number
- NCT01626547
- Sponsor
- Hospira, now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-12-01
- Primary completion
- 2012-12-01
- Enrollment
- 291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.